CoVepiT / OSE Immunotherapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CoVepiT / OSE Immunotherapeutics
COVEPIT 3, NCT04885361: To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults

Recruiting
1
48
Europe
CoVepiT (OSE13E)
OSE Immunotherapeutics
Coronavirus Disease (COVID-19)
09/21
03/22

Download Options